06.10.15
AMAG Pharmaceuticals has appointed Aaron Pelta as vice president of business development and transactions, reporting to Melissa Klug, senior vice president of business development and strategy. Mr. Pelta brings to AMAG more than 15 years of experience in corporate and business development, commercialization, strategy and operations, having executed multiple mergers, acquisitions and licensing deals.
“We’re delighted to welcome Aaron to AMAG and are pleased to have his strong abilities on board at a time when business development is a core strategic focus for our company,” said Ms. Klug.
Prior to joining AMAG, Mr. Pelta served in various positions of increasing responsibility in the business development and commercial groups at Cubist Pharmaceuticals from 2004 to 2015, including senior director, business development, where he led the transaction teams responsible for the acquisitions of Optimer Pharmaceuticals and Adolor Pharmaceuticals. Most recently, Mr. Pelta served as the brand lead for
DIFICID, where he led the commercial re-launch of the product.
“We’re delighted to welcome Aaron to AMAG and are pleased to have his strong abilities on board at a time when business development is a core strategic focus for our company,” said Ms. Klug.
Prior to joining AMAG, Mr. Pelta served in various positions of increasing responsibility in the business development and commercial groups at Cubist Pharmaceuticals from 2004 to 2015, including senior director, business development, where he led the transaction teams responsible for the acquisitions of Optimer Pharmaceuticals and Adolor Pharmaceuticals. Most recently, Mr. Pelta served as the brand lead for
DIFICID, where he led the commercial re-launch of the product.